ATTR Amyloidosis Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

ATTR Amyloidosis Treatment Market is segmented By Type (Hereditary ATTR Amyloidosis, Wild-type ATTR ...

ATTR Amyloidosis Treatment Market Size

Market Size in USD Bn

CAGR8.9%

Study Period2025-2032
Base Year of Estimation2024
CAGR8.9%
Market ConcentrationHigh
Major PlayersPfizer Inc., Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Eidos Therapeutics, Inc., Akcea Therapeutics, Inc. and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

ATTR Amyloidosis Treatment Market Analysis

The ATTR amyloidosis treatment market is estimated to be valued at USD 4.14 Bn in 2025 and is expected to reach USD 7.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. ATTR amyloidosis is a rare genetic disease with deposition of abnormal protein called amyloid in organs and tissues. Several treatment options and novel drug pipeline is expected to drive the growth of this market during the forecast period.

ATTR Amyloidosis Treatment Market Report Snapshots